Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus
NCT04120623
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Dapagliflozin 10 MG
DRUG:
Insulin Aspart
Sponsor
Nanjing First Hospital, Nanjing Medical University